Secondary Myelodysplastic Syndrome may Happen same as Paraneoplastic Syndrome in a Period of time and Prior to the Appearance of Malignancy: A Case Study of 6 Patients
Myelodysplastic syndrome is a bone marrow failure in which differentiation and maturity do not happen naturally and dysplasia exists in each of 3 cell categories in Bone marrow. Refractory anemia is one of the major complaints with which the patients come to hematology clinics, which in diagnostic c...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2013-04-01
|
| Series: | International Journal of Hematology-Oncology and Stem Cell Research |
| Subjects: | |
| Online Access: | http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/374/436 |
| _version_ | 1797711140364484608 |
|---|---|
| author | Mozaffar Aznab Kaveh Kavianymoghdam |
| author_facet | Mozaffar Aznab Kaveh Kavianymoghdam |
| author_sort | Mozaffar Aznab |
| collection | DOAJ |
| description | Myelodysplastic syndrome is a bone marrow failure in which differentiation and maturity do not happen naturally and dysplasia exists in each of 3 cell categories in Bone marrow. Refractory anemia is one of the major complaints with which the patients come to hematology clinics, which in diagnostic considerations lead to MDS as diagnosis. Often there is no recognized reason for this, so it is called “primary MDS”. In practice, we meet some patients who have MDS criteria however we can also find specific reasons for it; therefore we call it “secondary MDS”. One of the most important reasons for secondary MDS is the side effects of medications used in chemotherapy and radiotherapy in patients who undergo these therapies. We observed 6 patients in this case study during lengthy follow up that were diagnosed as MDS and during follow up period malignancy appeared in 6 cases. Supportive and therapeutic measures in these patients did not considerably improve blood cell count, most patients required blood injection and antibiotics for infection treatment. However align with malignancy treatment such problems are completely resolved both in terms of clinical and laboratory. |
| first_indexed | 2024-03-12T07:02:40Z |
| format | Article |
| id | doaj.art-ea8defb29dfc491aafd89f287a678f3e |
| institution | Directory Open Access Journal |
| issn | 2008-3009 2008-2207 |
| language | English |
| last_indexed | 2024-03-12T07:02:40Z |
| publishDate | 2013-04-01 |
| publisher | Tehran University of Medical Sciences |
| record_format | Article |
| series | International Journal of Hematology-Oncology and Stem Cell Research |
| spelling | doaj.art-ea8defb29dfc491aafd89f287a678f3e2023-09-02T23:40:11ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-30092008-22072013-04-01723033Secondary Myelodysplastic Syndrome may Happen same as Paraneoplastic Syndrome in a Period of time and Prior to the Appearance of Malignancy: A Case Study of 6 PatientsMozaffar AznabKaveh KavianymoghdamMyelodysplastic syndrome is a bone marrow failure in which differentiation and maturity do not happen naturally and dysplasia exists in each of 3 cell categories in Bone marrow. Refractory anemia is one of the major complaints with which the patients come to hematology clinics, which in diagnostic considerations lead to MDS as diagnosis. Often there is no recognized reason for this, so it is called “primary MDS”. In practice, we meet some patients who have MDS criteria however we can also find specific reasons for it; therefore we call it “secondary MDS”. One of the most important reasons for secondary MDS is the side effects of medications used in chemotherapy and radiotherapy in patients who undergo these therapies. We observed 6 patients in this case study during lengthy follow up that were diagnosed as MDS and during follow up period malignancy appeared in 6 cases. Supportive and therapeutic measures in these patients did not considerably improve blood cell count, most patients required blood injection and antibiotics for infection treatment. However align with malignancy treatment such problems are completely resolved both in terms of clinical and laboratory.http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/374/436Myelodysplastic SyndromeParaneoplastic SyndromeMalignancy |
| spellingShingle | Mozaffar Aznab Kaveh Kavianymoghdam Secondary Myelodysplastic Syndrome may Happen same as Paraneoplastic Syndrome in a Period of time and Prior to the Appearance of Malignancy: A Case Study of 6 Patients International Journal of Hematology-Oncology and Stem Cell Research Myelodysplastic Syndrome Paraneoplastic Syndrome Malignancy |
| title | Secondary Myelodysplastic Syndrome may Happen same as Paraneoplastic Syndrome in a Period of time and Prior to the Appearance of Malignancy: A Case Study of 6 Patients |
| title_full | Secondary Myelodysplastic Syndrome may Happen same as Paraneoplastic Syndrome in a Period of time and Prior to the Appearance of Malignancy: A Case Study of 6 Patients |
| title_fullStr | Secondary Myelodysplastic Syndrome may Happen same as Paraneoplastic Syndrome in a Period of time and Prior to the Appearance of Malignancy: A Case Study of 6 Patients |
| title_full_unstemmed | Secondary Myelodysplastic Syndrome may Happen same as Paraneoplastic Syndrome in a Period of time and Prior to the Appearance of Malignancy: A Case Study of 6 Patients |
| title_short | Secondary Myelodysplastic Syndrome may Happen same as Paraneoplastic Syndrome in a Period of time and Prior to the Appearance of Malignancy: A Case Study of 6 Patients |
| title_sort | secondary myelodysplastic syndrome may happen same as paraneoplastic syndrome in a period of time and prior to the appearance of malignancy a case study of 6 patients |
| topic | Myelodysplastic Syndrome Paraneoplastic Syndrome Malignancy |
| url | http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/374/436 |
| work_keys_str_mv | AT mozaffaraznab secondarymyelodysplasticsyndromemayhappensameasparaneoplasticsyndromeinaperiodoftimeandpriortotheappearanceofmalignancyacasestudyof6patients AT kavehkavianymoghdam secondarymyelodysplasticsyndromemayhappensameasparaneoplasticsyndromeinaperiodoftimeandpriortotheappearanceofmalignancyacasestudyof6patients |